For the past fifty years, UC San Francisco (UCSF) has played a prominent role in medical research, with several of its faculty members receiving Nobel Prizes for discoveries that have influenced science and medicine.
Since the Nobel Prize in physiology or medicine was first awarded in 1901, UCSF faculty have won six of these honors. This places UCSF among the leading U.S. medical schools in terms of Nobel recognitions.
David Julius, Ph.D., a professor at UCSF, received the Nobel Prize in 2021 for his work on how humans sense pain, heat, and touch. By studying substances such as tarantula toxins and capsaicin from chili peppers, Julius identified proteins that are essential to sensory pathways in the nervous system. He explained: “Science is a lot like real estate: It’s about location, location, location.” His research has provided new insights into pain at the molecular level and may help lead to safer pain treatments.
In 2007, Shinya Yamanaka, M.D., Ph.D., also a professor at UCSF, discovered how to reprogram mature cells to return them to a pluripotent state—meaning they can become almost any type of cell. This breakthrough created new fields of research and opportunities for developing treatments for diseases such as Alzheimer’s and heart disease.
Elizabeth Blackburn, Ph.D., another UCSF faculty member, found that chromosomes are protected by structures called telomeres. Her discovery addressed how chromosomes can be copied fully during cell division. Research on telomeres now informs studies on cancer therapies and aging.
Stanley Prusiner, M.D., uncovered prions as infectious proteins responsible for diseases like Kuru and Creutzfeldt–Jakob disease. Since his Nobel Prize win in 1997, scientists at UCSF have continued exploring how prion-like proteins might contribute to neurodegenerative conditions such as Parkinson’s disease.
J. Michael Bishop and Harold E. Varmus made significant contributions by identifying oncogenes—mutated genes that cause cancer—in normal cells rather than just viruses or external agents. Their work led to advances in cancer care by enabling researchers to identify specific genes linked to aggressive cancers and develop targeted therapies like Herceptin.
These discoveries highlight UCSF’s ongoing impact on scientific understanding and patient care through fundamental research achievements.
